Figure 7From: The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatmentEffect of treatment on the spread of resistance. A: Switch of first-line treatment in 2014 from ACT to the same coverage of 72% with atovaquone-proguanil and the resulting spread of atovaquone resistance. B: increase of ACT coverage in 2014 to 95% and artemisinin resistance.Back to article page